Increased urinary C-peptide and albumin excretion in juvenile borderline hypertensives. 1993

K Narkiewicz, and A Rynkiewicz, and J Furmański, and L Bieniaszewski, and K Bartłomiejczyk-Majchrowicz, and S Andrzejewska, and M Kowalczyk, and W Lysiak-Szydłowska, and B Krupa-Wojciechowska
Department of Hypertension and Diabetology, Medical School of Gdańsk, Poland.

The study was designed to evaluate the urinary excretion of C-peptide and albumin, and urinary N-acetyl-beta-D-glucosaminidase (NAG) activity in juvenile borderline hypertensives. The second aim was to examine the relationship between these variables and ambulatory blood pressure level and variability. The study group consisted of 21 non-obese males consecutively chosen from patients with borderline hypertension, defined by sphygmanometer readings, examined in our outpatient clinic. All subjects collected separately their day-time and night-time urines during the period of ambulatory blood pressure monitoring. In 16 patients, who were considered to have "sustained" borderline hypertension, both 24-h urinary C-peptide excretion and 24-h UAE were significantly increased in comparison to those of the controls, while NAG activity did not differ significantly between the two groups. UAE was significantly lower at night than during the day in both borderline hypertensives and controls. Twenty-four-hour UAE in borderline hypertensives correlated significantly with the ambulatory blood pressure variability, but not with the average blood pressure level. These results suggest that the 24-h insulin secretion rate estimated by means of urinary C-peptide excretion is significantly increased in "sustained" borderline hypertensives. Elevated UAE in juvenile borderline hypertensives can be explained by a possible direct effect of systemic blood pressure variability on albuminuria.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000118 Acetylglucosaminidase A beta-N-Acetylhexosaminidase that catalyzes the hydrolysis of terminal, non-reducing 2-acetamido-2-deoxy-beta-glucose residues in chitobiose and higher analogs as well as in glycoproteins. Has been used widely in structural studies on bacterial cell walls and in the study of diseases such as MUCOLIPIDOSIS and various inflammatory disorders of muscle and connective tissue. N-Acetyl-beta-D-glucosaminidase,Chitobiase,N,N-Diacetylchitobiase,N-Ac-beta-Glucosaminidase,NAGase,beta-D-Acetamido-2-Deoxyglucosidase,beta-D-N-acetylglucosaminidase,beta-N-Acetylglucosaminidase,N Ac beta Glucosaminidase,N Acetyl beta D glucosaminidase,N,N Diacetylchitobiase,beta D Acetamido 2 Deoxyglucosidase,beta D N acetylglucosaminidase,beta N Acetylglucosaminidase
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000419 Albuminuria The presence of albumin in the urine, an indicator of KIDNEY DISEASES. Albuminurias
D015924 Blood Pressure Monitors Devices for continuously measuring and displaying the arterial blood pressure. Monitors, Blood Pressure,Sphygmomanometers, Continuous,Blood Pressure Monitor,Continuous Sphygmomanometer,Continuous Sphygmomanometers,Monitor, Blood Pressure,Pressure Monitor, Blood,Pressure Monitors, Blood,Sphygmomanometer, Continuous

Related Publications

K Narkiewicz, and A Rynkiewicz, and J Furmański, and L Bieniaszewski, and K Bartłomiejczyk-Majchrowicz, and S Andrzejewska, and M Kowalczyk, and W Lysiak-Szydłowska, and B Krupa-Wojciechowska
October 1971, Scandinavian journal of clinical and laboratory investigation,
K Narkiewicz, and A Rynkiewicz, and J Furmański, and L Bieniaszewski, and K Bartłomiejczyk-Majchrowicz, and S Andrzejewska, and M Kowalczyk, and W Lysiak-Szydłowska, and B Krupa-Wojciechowska
October 2000, Nephron,
K Narkiewicz, and A Rynkiewicz, and J Furmański, and L Bieniaszewski, and K Bartłomiejczyk-Majchrowicz, and S Andrzejewska, and M Kowalczyk, and W Lysiak-Szydłowska, and B Krupa-Wojciechowska
January 1983, Clinical and experimental hypertension. Part A, Theory and practice,
K Narkiewicz, and A Rynkiewicz, and J Furmański, and L Bieniaszewski, and K Bartłomiejczyk-Majchrowicz, and S Andrzejewska, and M Kowalczyk, and W Lysiak-Szydłowska, and B Krupa-Wojciechowska
March 2011, Hypertension (Dallas, Tex. : 1979),
K Narkiewicz, and A Rynkiewicz, and J Furmański, and L Bieniaszewski, and K Bartłomiejczyk-Majchrowicz, and S Andrzejewska, and M Kowalczyk, and W Lysiak-Szydłowska, and B Krupa-Wojciechowska
January 1999, West African journal of medicine,
K Narkiewicz, and A Rynkiewicz, and J Furmański, and L Bieniaszewski, and K Bartłomiejczyk-Majchrowicz, and S Andrzejewska, and M Kowalczyk, and W Lysiak-Szydłowska, and B Krupa-Wojciechowska
February 1997, Journal of human hypertension,
K Narkiewicz, and A Rynkiewicz, and J Furmański, and L Bieniaszewski, and K Bartłomiejczyk-Majchrowicz, and S Andrzejewska, and M Kowalczyk, and W Lysiak-Szydłowska, and B Krupa-Wojciechowska
January 2000, Acta oncologica (Stockholm, Sweden),
K Narkiewicz, and A Rynkiewicz, and J Furmański, and L Bieniaszewski, and K Bartłomiejczyk-Majchrowicz, and S Andrzejewska, and M Kowalczyk, and W Lysiak-Szydłowska, and B Krupa-Wojciechowska
June 1974, Lancet (London, England),
K Narkiewicz, and A Rynkiewicz, and J Furmański, and L Bieniaszewski, and K Bartłomiejczyk-Majchrowicz, and S Andrzejewska, and M Kowalczyk, and W Lysiak-Szydłowska, and B Krupa-Wojciechowska
December 1986, Endocrinologia experimentalis,
K Narkiewicz, and A Rynkiewicz, and J Furmański, and L Bieniaszewski, and K Bartłomiejczyk-Majchrowicz, and S Andrzejewska, and M Kowalczyk, and W Lysiak-Szydłowska, and B Krupa-Wojciechowska
March 2013, Hypertension research : official journal of the Japanese Society of Hypertension,
Copied contents to your clipboard!